TOVX - Theriva Biologics Inc Stock Price & Dividend Safety Sector: Healthcare | Exchange: New York Stock Exchange Arca Current Price & Safety Score Price: 0.19 USD StockBonds Safety Grade: Altman Z-Score (Bankruptcy Risk): -15.42 StockBond Score: -5.03 Company Description Theriva Biologics Inc is a clinicalstage biotechnology firm dedicated to developing novel treatments for conditions with significant unmet medical needs The companys pipeline features several promising candidates including SYN004 which is engineered to break down commonly used intravenous betalactam antibiotics in the gastrointestinal tract This degradation aims to avert microbiome damage Clostridioides difficile infection CDI the overgrowth of harmful organisms the rise of antimicrobial resistance AMR and acute graftversushost disease aGVHD in patients undergoing allogeneic hematopoietic cell transplants Another key investigational therapy is SYN020 an orally administered recombinant formulation of intestinal alkaline phosphatase designed to address both localized gastrointestinal and systemic diseases Additionally Theriva Biologics is advancing VCN01 for the treatment of various cancers specifically pancreatic cancer head and neck squamous cell carcinoma colorectal cancer and retinoblastoma Its broader clinicalstage portfolio includes SYN006 intended to prevent aGVHD and infections caused by carbapenemresistant enterococci SYN007 aimed at preventing antibioticassociated diarrhea linked to oral betalactam antibiotics SYN005 for both the prevention and treatment of pertussis and VCN11 another cancerfocused therapy The company collaborates with institutions such as Intrexon Corporation The University of Texas at Austin and CedarsSinai Medical Center Furthermore a clinical trial agreement with Washington University School of Medicine in St Louis is in place to conduct a Phase 1b2a clinical trial for SYN004 Formerly known as Synthetic Biologics Inc the company rebranded as Theriva Biologics Inc in October 2022 and is headquartered in Rockville Maryland